| 80.98 Delayed Data As of May 22 |  +1.48 / +1.86%Today’s Change | 58.03 Today|||52-Week Range 83.85 | +5.98% Year-to-Date |
| Previous close | 79.50 |
| Today’s open | 79.35 |
| Day’s range | 79.31 - 81.15 |
| Volume | 12,873,869 |
| Average volume (3 months) | 10,954,018 |
| Market cap | $202.7B |
| Earnings growth (last year) | +165.32% |
| Earnings growth (this year) | +9.30% |
| Earnings growth (next 5 years) | +8.45% |
| Revenue growth (last year) | +6.17% |
| P/E ratio | 25.5 |
| Price/Sales | 4.82 |
| Price/Book | 7.64 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +1.52 | +1.84% |
| PFEPfizer | +0.32 | +0.77% |
| ABTAbbott Laboratories | +0.23 | +0.30% |
| ABBVAbbVie | +0.71 | +0.88% |
| Next reporting date | August 8, 2019 |
| EPS forecast (this quarter) | $1.14 |
| Annual revenue (last year) | $42.4B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 14.65% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer Kenneth C. Frazier |
CFO & Executive Vice President-Global Services Robert M. Davis |
Corporate headquarters Kenilworth, New Jersey |
